Silo Pharma (SILO) Other Operating Expenses (2017 - 2026)
Silo Pharma (SILO) posted Other Operating Expenses of -$29911.0 for Q1 2026, down 101.41% sequentially from $2.1 million in Q4 2025, and down 105.79% YoY from $516725.0 in Q1 2025.
Silo Pharma (SILO) Other Operating Expenses (2017 - 2026) Analysis & Trends
Silo Pharma has reported Other Operating Expenses for 10 years, with the latest figure at -$29911.0 in Q1 2026.
- Quarterly Other Operating Expenses fell 105.79% year-over-year to -$29911.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.2 million (up 37.68% YoY) and the FY2025 annual result came in at -$39916.0, down 101.66% from the prior year.
- Other Operating Expenses eased to -$29911.0 in Q1 2026 per SILO's latest filing, from $2.1 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at $2.2 million in Q4 2022 and troughed at -$29911.0 in Q1 2026.
- A 5-year average of $729952.5 and a median of $575947.0 in 2024 frame the typical range for Other Operating Expenses.
- The sharpest annual moves came in 2025 and 2026: Other Operating Expenses jumped 181.15% in 2025, then plunged 105.79% in 2026.
- Over 5 years, Other Operating Expenses stood at $2.2 million in 2022, then slumped by 61.99% to $843325.0 in 2023, then dropped by 10.57% to $754199.0 in 2024, then surged by 181.15% to $2.1 million in 2025, then sank by 101.41% to -$29911.0 in 2026.
- According to Business Quant data, Other Operating Expenses over the past three periods registered -$29911.0, $2.1 million, and $605189.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Silo Pharma | 2.92 Mn | 2.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29,911.00 |
| Dec 31, 2025 | 2.12 Mn |
| Sep 30, 2025 | 605,189.00 |
| Jun 30, 2025 | 547,870.00 |
| Mar 31, 2025 | 516,725.00 |
| Dec 31, 2024 | 754,199.00 |
| Sep 30, 2024 | 509,073.00 |
| Jun 30, 2024 | 575,947.00 |
| Mar 31, 2024 | 513,477.00 |
| Dec 31, 2023 | 843,325.00 |
| Sep 30, 2023 | 615,469.00 |
| Jun 30, 2023 | 761,732.00 |
| Mar 31, 2023 | 611,477.00 |
| Dec 31, 2022 | 2.22 Mn |
| Sep 30, 2022 | 529,584.00 |
| Jun 30, 2022 | 379,257.00 |
| Mar 31, 2022 | 336,721.00 |
| Dec 31, 2021 | 1.11 Mn |
| Sep 30, 2021 | 385,376.00 |
| Jun 30, 2021 | 308,863.00 |